Health Technology

Tivic Health Partners With InStep Health to Access Over 2,500 Healthcare Providers and Their Patients.

Retrieved on: 
Tuesday, September 26, 2023
Biotechnology, Medical Devices, Health, Pharmaceutical, Health Technology, System, Foot, Education, Allergy, Sinusitis, Pharmacy, Otorhinolaryngology, Allergic rhinitis, HCP, Allergist, Patient, Physician, OTC, FDA, Headache, Pharmaceutical industry

Tivic Health® Systems, Inc. (“Tivic”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, announced today that it has signed an agreement with InStep Health® to introduce the Company’s bioelectronic sinus device, ClearUP®, to over 2,500 healthcare providers (HCP) and their patients.

Key Points: 
  • Tivic Health® Systems, Inc. (“Tivic”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, announced today that it has signed an agreement with InStep Health® to introduce the Company’s bioelectronic sinus device, ClearUP®, to over 2,500 healthcare providers (HCP) and their patients.
  • InStep Health assists pharmaceutical, OTC, and consumer-packaged brands to reach consumers at the center of care, whether in the doctor’s office, pharmacy, or within the store aisles.
  • Tivic’s program with InStep Health will reach allergists, ENTs, and primary care providers through in-office provider education kits, provider 1:1 email campaigns, and digital advertising.
  • “The InStep Health program is a cost-effective way to reach key physicians who are highly influential in the buying decision for patients with allergic rhinitis, sinus infections, head pain, and congestion,” says Jennifer Ernst, CEO of Tivic.

Gozio Health Launches Marketplace to Promote Optimal Mobile Strategy Execution for Health Systems and Their Patients

Retrieved on: 
Tuesday, September 26, 2023
Software, Mobile, Wireless, General Health, Telemedicine, Virtual Medicine, Data Management, Apps, Applications, Technology, Hospitals, Artificial Intelligence, Health Technology, Practice Management, Health, Communication, Health equity, Patient, Prisma Health, Baptist Health, CIO, ROI, SVP, SMS, Mobile phone, Online shopping, Hyro the Hero

Gozio Health , an open, industry-leading, location-aware digital health platform, today announced it has launched a marketplace of vendors to foster collaboration between health systems and digital application partners.

Key Points: 
  • Gozio Health , an open, industry-leading, location-aware digital health platform, today announced it has launched a marketplace of vendors to foster collaboration between health systems and digital application partners.
  • The new marketplace complements Gozio’s open platform, which allows health systems to customize how they bring together digital experiences into a single health system app, as well as develop unique digital experiences across a wide variety of stakeholders.
  • "We appreciate that Gozio sat down with us as a partner and made some suggestions on how we could increase engagement with patients through our mobile app.
  • Piedmont Healthcare has also realized significant adoption rates through the Gozio platform, with over 300,000 downloads of its branded mobile app.

Research2Guidance Launches Allis.Health, a New Digital Health Analyst Platform Developed by Healthware Group

Retrieved on: 
Tuesday, September 26, 2023
Software, Data Analytics, Managed Care, Health, Consulting, Health Technology, Professional Services, Technology, Single-frequency network, Ambassador, Multimedia, Consultant, Allis, Digital health, Drug discovery, News Watch (Indonesian TV series), AI, Digital, Healthware International, Mental health, News, KPI-driven code analysis, Retail, Pharma, Femtech

Allis.Health , the new digital health market insight platform, is organized into market segments, acknowledging the fact that the digital health market has grown dynamically and differently within each one.

Key Points: 
  • Allis.Health , the new digital health market insight platform, is organized into market segments, acknowledging the fact that the digital health market has grown dynamically and differently within each one.
  • View the full release here: https://www.businesswire.com/news/home/20230926023449/en/
    Introducing a New Digital Health Platform - Allis.Health (Graphic: Business Wire)
    Allis.Health goes beyond merely displaying news or competitor data.
  • By placing facts into context, Allis equips digital health decision-makers with actionable insights to make informed decisions whenever needed.
  • "We created Allis.Health with the aim of offering digital health managers, investors, researchers, or even consultants a market and competitor monitoring tool for the global digital health market to support their tactical and strategic decisions.

Cytel continues expansion of market access and medical communication capabilities with the acquisition of co.faktor

Retrieved on: 
Tuesday, September 26, 2023
Technology, Clinical Trials, Health Technology, Software, Biotechnology, Health, Pharmaceutical, General Health, Data Management, Inc., German, Clinical trial, HTA, Multimedia, Gesellschaft mit beschränkter Haftung, Acquisition, RWE, Health technology assessment, Pharmaceutical industry, EU, Cytel

As a result, Cytel’s services for biopharma commercialization will gain new and complementary specialist consultancy capabilities and localized expertise for successful market access in Germany, a first wave launch country.

Key Points: 
  • As a result, Cytel’s services for biopharma commercialization will gain new and complementary specialist consultancy capabilities and localized expertise for successful market access in Germany, a first wave launch country.
  • The acquisition marks another milestone in Cytel’s strategic growth in Europe, and follows the recent acquisition of stève consultants, specialists in market access, real-world evidence (RWE), and health economics and outcomes research (HEOR) in France.
  • Achieving favorable market access in today’s global healthcare industry is challenging and requires deep knowledge of EU national regulations.
  • Cytel’s most recent acquisition of the co.faktor businesses continues this investment, augmenting and extending localized regulatory support through product launch and commercialization.

Exactech Names Darin Johnson CEO

Retrieved on: 
Tuesday, September 26, 2023
Technology, Surgery, Medical Devices, Health Technology, Software, Health, General Health, Data Management, Artificial Intelligence, Ankle, Human resources, Surgeon, Hip, Shoulder, Foot, Humerus, Multimedia, TPG, Information, Patient, Binder, Johnson, Knee, Management, Chime

Exactech , a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced that Darin Johnson, current Exactech President, has been promoted to CEO.

Key Points: 
  • Exactech , a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced that Darin Johnson, current Exactech President, has been promoted to CEO.
  • Johnson, who has served as interim CEO since March 2023, succeeds Jeffrey Binder, Chairman of Exactech’s Board of Directors.
  • View the full release here: https://www.businesswire.com/news/home/20230925567645/en/
    Exactech Names Darin Johnson CEO (Photo: Business Wire)
    Johnson joined Exactech in 2002 and has since held several executive-level leadership roles with the company.
  • “Darin has done an excellent job guiding Exactech over the past six months,” Binder said.

Hinge Health Continues to Advance Women’s Pelvic Care with Breathing Guidance and Smart Trainer Device

Retrieved on: 
Tuesday, September 26, 2023
Consumer Electronics, Technology, Health, Women, Wearables, Mobile Technology, Health Technology, Medical Devices, Apps, Applications, Software, Consumer, Telemedicine, Virtual Medicine, Exercise, DSM-IV codes, Pelvic pain, Pregnancy, Pit additive, Life, Anxiety, Therapy, Incontinence, Woman, Pelvic floor, Abdomen, Weightlifting, Swelling, Menopause, Happiness, Meditation, Research, Mental health, Urinary incontinence, Birth control

Hinge Health’s Pelvic Health Program has seen tremendous adoption and effectiveness with over 15,000 participants enrolling since the program was introduced in May 2023.

Key Points: 
  • Hinge Health’s Pelvic Health Program has seen tremendous adoption and effectiveness with over 15,000 participants enrolling since the program was introduced in May 2023.
  • “For too long, women have been suffering in silence with pelvic conditions, without access to high-quality care,” said Inessa Lurye, Head of Women’s Health at Hinge Health.
  • Breathing Guidance: A new breathing and meditation experience helps members reduce stress and anxiety as well as decrease muscle tension, which can help women address their pelvic health symptoms.
  • Care is personalized around one of four pelvic floor needs: pregnancy and postpartum, bladder control, pelvic pain, and pelvic strength.

Higi Selects ThoroughCare to Assist in Managing Chronically Ill Patients

Retrieved on: 
Tuesday, September 26, 2023
Data Management, Practice Management, Technology, Physical Therapy, Diabetes, General Health, Telemedicine, Virtual Medicine, Other Health, Apps, Applications, Mental Health, Insurance, Health Technology, Biometrics, Health Insurance, Cardiology, Professional Services, Biotechnology, IOT (Internet of Things), Software, Health, Internet, Data management, Partnership, Workflow, ModivCare, Data collection, Patient, Growth, Nursing, Higi

ThoroughCare, Inc., a leading care coordination organization, continues to demonstrate operational growth and success, today announced a new partnership with Higi, a Modivcare service (Nasdaq: MODV).

Key Points: 
  • ThoroughCare, Inc., a leading care coordination organization, continues to demonstrate operational growth and success, today announced a new partnership with Higi, a Modivcare service (Nasdaq: MODV).
  • Higi was acquired by Modivcare in March 2023 and supports Modivcare’s development of the leading integrated supportive care platform for individuals living with complex health conditions.
  • Higi will implement ThoroughCare’s integrated care coordination software platform as part of Higi’s complex care management solution to provide data collection and care management services for chronically ill and vulnerable patients.
  • “By integrating ThoroughCare’s platform, the Higi Care Management team will be better equipped to provide our patients with the care and guidance they need,” said Jeff Bennett, CEO of Higi.

Sonendo, Inc. Announces Inducement Grants Under NYSE Listing Rule 303A.08

Retrieved on: 
Tuesday, September 26, 2023
Health Technology, Health, Dental, Medical Devices, NYSE, Compensated emancipation, Pharmaceutical industry

Sonendo , Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that on September 25, 2023, the Compensation Committee of Sonendo’s Board of Directors granted restricted stock unit awards covering an aggregate of 14,000 shares of its common stock to two new, non-executive employees to induce them to join the company.

Key Points: 
  • Sonendo , Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that on September 25, 2023, the Compensation Committee of Sonendo’s Board of Directors granted restricted stock unit awards covering an aggregate of 14,000 shares of its common stock to two new, non-executive employees to induce them to join the company.
  • The awards were granted under Sonendo’s 2023 Employment Inducement Incentive Award Plan (the “Inducement Plan”), which was adopted on March 2, 2023 and provides for the granting of equity awards to prospective employees of Sonendo under NYSE Listing Rule 303A.08.
  • The restricted stock unit awards vest over a four-year period, with twenty five percent of the shares underlying each award vesting on the anniversary of the award’s vesting commencement date, September 25, 2023, and six and one-quarter percent of the shares underlying each award vesting quarterly thereafter, subject to continued service.
  • The restricted stock units are subject to the terms and conditions of the Inducement Award Plan.

Jackson Healthcare Ranked #8 on Global List of Top 100 Inspiring Workplaces

Retrieved on: 
Tuesday, September 26, 2023
Professional Services, Health, Hospitals, Practice Management, Health Technology, Human Resources, General Health, Workplace, Organization, Communication, Culture, Nursing, Management

Jackson Healthcare® today announced it has been selected for the inaugural “Global Top 100 Inspiring Workplaces” list .

Key Points: 
  • Jackson Healthcare® today announced it has been selected for the inaugural “Global Top 100 Inspiring Workplaces” list .
  • The award program is organized by the Inspiring Workplaces Group, a global organization championing positive change within and beyond the office.
  • Earlier this year, Jackson Healthcare earned recognition on the annual “Top 50 Most Inspiring Workplaces North America” list, ranking fourth overall.
  • “It is with pride that we publish the Top 100 Global Inspiring Workplaces list for the very first time.

Senseonics Announces the Last Patient Completion of the 365-Day ENHANCE Pivotal Clinical Study

Retrieved on: 
Tuesday, September 26, 2023
Research, Apps, Applications, Technology, Medical Devices, Diabetes, Clinical Trials, Health Technology, Biotechnology, Health, Science, CGM, Trial of the century, GlySens ICGM, FDA, NYSE, Patient, SENS, Safety, Medical device

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced the completion of the ENHANCE Pivotal Clinical Study adult cohort following the recently completed 365-day visit for the final study patient.

Key Points: 
  • Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced the completion of the ENHANCE Pivotal Clinical Study adult cohort following the recently completed 365-day visit for the final study patient.
  • “We are pleased that all patients have completed the testing for the adult arm of the ENHANCE clinical study.
  • Demonstration of safe and accurate performance of Eversense® for 365 days in this study would further validate its ability to facilitate more effective and longer-term management of diabetes.
  • Data gathered in this study was also used to support the FDA submission for the integrated continuous glucose monitoring, iCGM, designation earlier in 2023.